14-3-3 binding regulates catalytic activity of human Wee1 kinase

C J Rothblum-Oviatt1, C E Ryan, H Piwnica-Worms

  • 1Department of Cell Biology and Physiology, Howard Hughes Medical Institute, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, Missouri 63110, USA.

Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|December 26, 2001
PubMed

Insights

14-3-3 proteins positively regulate human Wee1, a key kinase in cell cycle control. Reduced binding during mitosis and impaired function of non-binding Wee1 mutants highlight 14-3-3's crucial role.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • The cell cycle is tightly regulated by protein kinases, including Cdc2.
  • Wee1 kinase phosphorylates Cdc2 at tyrosine 15, inhibiting its activity and inducing cell cycle arrest.
  • Human Wee1 is regulated by phosphorylation, proteolysis, and protein interactions.

Purpose of the Study:

  • To investigate the role of 14-3-3 protein interactions in regulating human Wee1 kinase activity and function.
  • To determine how 14-3-3 binding to Wee1 changes during the cell cycle.

Main Methods:

  • Studied 14-3-3 binding to human Wee1 using biochemical assays.
  • Utilized a Wee1 mutant unable to bind 14-3-3 proteins.
  • Assessed enzymatic activity and cell cycle delay (G2) in vivo.

Main Results:

  • 14-3-3 binding to human Wee1 decreases during mitosis.
  • 14-3-3 binding remains stable when treated with the protein kinase inhibitor UCN-01.
  • Wee1 mutants lacking 14-3-3 binding exhibit reduced enzymatic activity and potency in inducing G2 delay.

Conclusions:

  • 14-3-3 proteins act as positive regulators of human Wee1 kinase activity.
  • 14-3-3 binding is essential for Wee1's function in cell cycle progression.

Related Concept Videos

Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...